Bladder Cancer

Latest News

FDA approval sought for UGN-102 for low-grade intermediate-risk NMIBC
FDA approval sought for UGN-102 for low-grade intermediate-risk NMIBC

March 15th 2024

The application for UGN-102 for low-grade intermediate-risk non–muscle-invasive bladder cancer is based on findings from the phase 3 ENVISION trial.

Liquid biopsy tests may enhance bladder cancer detection
Liquid biopsy tests may enhance bladder cancer detection

March 11th 2024

FDA approves nivolumab plus cisplatin/gemcitabine in urothelial carcinoma
FDA approves nivolumab plus cisplatin/gemcitabine in urothelial carcinoma

March 7th 2024

EV-302 data on EV/pembro in urothelial carcinoma published in NEJM
EV-302 data on EV/pembro in urothelial carcinoma published in NEJM

March 7th 2024

CMS establishes payment rate for Oncuria bladder cancer tests
CMS establishes payment rate for Oncuria bladder cancer tests

March 5th 2024

Video Series
Video Interviews
Podcasts
medical depiction of bladder cancer

More News

© 2024 MJH Life Sciences

All rights reserved.